Literature DB >> 27018042

Thymoma-associated cutaneous graft-versus-host-like disease possibly treated with Narrow-band UVB phototherapy.

Minako Nakayama1, Munenari Itoh1, Sota Kikuchi1, Katsumi Tanito1, Hidemi Nakagawa1.   

Abstract

Mesh:

Year:  2016        PMID: 27018042     DOI: 10.1684/ejd.2015.2716

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  4 in total

1.  Multimodal immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated multiorgan autoimmunity.

Authors:  Hiroo Kasahara; Kazuki Shimizu; Kouki Makioka; Takaaki Sano; Yoichi Ohtaki; Yoshio Ikeda
Journal:  Immunol Res       Date:  2022-03-14       Impact factor: 2.829

Review 2.  Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review.

Authors:  Ewa Wrona; Sylwia Dębska-Szmich; Marta Pastuszka; Marcin Braun; Rafał Czyżykowski; Piotr Potemski
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

3.  Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid Dermatitis.

Authors:  Farzan Solimani; Roberto Maglie; Robert Pollmann; Thomas Schmidt; Ansgar Schmidt; Norito Ishii; Björn Tackenberg; Andreas Kirschbaum; Dario Didona; Julia Pickert; Rüdiger Eming; Takashi Hashimoto; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

4.  A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunity.

Authors:  Yuta Nakagawa; Kinnosuke Matsumoto; Makoto Yamamoto; Haruhiko Hirata; Takayuki Shiroyama; Kotaro Miyake; Yuji Yamamoto; Tomoki Kuge; Midori Yoneda; Yujiro Naito; Yasuhiko Suga; Kiyoharu Fukushima; Shohei Koyama; Kota Iwahori; Izumi Nagatomo; Yoshito Takeda; Atsushi Kumanogoh
Journal:  Respir Med Case Rep       Date:  2022-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.